CCI clears Berhyanda’s acquisition of up to 76.10% of Suven Pharmaceuticals

Suven Pharmaceuticals

Suven Pharmaceuticals, The Competition Commission of India (CCI) has approved the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals by Berhyanda. Berhyanda is the wholly owned subsidiary of Berhyanda Midco, i.e. in turn the wholly owned subsidiary of Jusmiral Midco.